TITLE

Bayer's Schering scheme rules it out of Pfizer bid

PUB. DATE

June 2006

SOURCE

ICIS Chemical Business;6/12/2006, Vol. 1 Issue 23, p4

SOURCE TYPE

Trade Publication

DOC. TYPE

Article

ABSTRACT

The article reports on the bid proposal of Bayer for the acquisition of the over-the-counter drugs business of Pfizer, which is Schering. Before the proposed Schering deal, Bayer had been concentrating on building its over-the-counter segment, and is believed to have bid for the Boots activities that later went to Reckitt Benckiser. Bayer chairman Werner Wenning said that they are convinced that the merger will create a healthcare heavyweight of international standing.

ACCESSION #

21428399

Tags: LETTING of contracts;  CONSOLIDATION & merger of corporations;  BAYER AG;  PFIZER Inc.;  DRUGS, Nonprescription

 

Related Articles

• Bayer to Buy Eastern European OTC Business. Walsh, Kerri // Chemical Week;3/17/2008, Vol. 170 Issue 9, p17 

  No abstract available.

• Degussa in the Running for H&R.  // Chemical Week;4/24/2002, Vol. 164 Issue 17, p14 

  Reports that Bayer has confirmed that Degussa is among the several bidders conducting diligence for Haarmann & Reimer (H&R), the flavors and fragrances subsidiary of Bayer. Price in which Bayer wants to sell H&R.

• Pharmaceutical Company Round-up.  // PharmaWatch: Monthly Review;Nov2006, Vol. 5 Issue 11, p3 

  No abstract available.

• Reckitt link to Pfizer bid. Robinson, Simon // ICIS Chemical Business;3/27/2006, Vol. 1 Issue 12, p10 

  The article reports that British household cleaning and over-the-counter (OTC) medicines producer Reckitt-Benckiser has been speculated as a bidder for Consumer Healthcare, the OTC medicines arm of Pfizer, in 2006. Reckitt was said to have engaged advisors including banks Merrill Lynch and...

• Bayer's bid wins Roche's otc arm.  // European Chemical News;7/26/2004, Vol. 81 Issue 2110, p9 

  Announces that Bayer won its bid to acquire Roche's over-the-counter (OTC) drugs business in Europe in 2004. Amount paid by Bayer for the acquisition; Purpose of proceeds from the sale; Location of the headquarters of the new Bayer OTC unit.

• Pharmaceuticals in Germany.  // Pharmaceuticals Industry Profile: Germany;January 2003, pN.PAG 

  Presents a profile of the Pharmaceuticals industry in Germany. Background on Datamonitor, a business information company specializing in industry analysis; Executive summary of the industry; Market overview; Market value; Market segmentation; Competitive landscape; Leading companies in the...

• Pharmaceuticals in China.  // Pharmaceuticals Industry Profile: China;January 2003, pN.PAG 

  Presents a profile of the Pharmaceuticals industry in China. Background on Datamonitor, a business information company specializing in industry analysis; Executive summary of the industry; Market overview; Market value; Market segmentation; Competitive landscape; Leading companies in the...

• Pharmaceuticals in Europe.  // Pharmaceuticals Industry Profile: Europe;November 2004, p1 

  Presents a profile of the Pharmaceuticals industry in Europe. Background on Datamonitor, a business information company specializing in industry analysis; Executive summary of the industry; Market overview; Market value; Market segmentation; Competitive landscape; Leading companies in the...

• Hostile Bidders, Long-Term Performance, and Restructuring Methods: Evidence from the UK. Raj, Mahendra; Forsyth, Michael // American Business Review;Jan2002, Vol. 20 Issue 1, p71 

  Examines the pre- and post-long-term performance of hostile bidders in Great Britain. Announcement of a hostile takeover bid; Redeployment of assets after takeover; Structural changes within a firm.

Read the Article